
Medicine shortage reports database
The medicine shortage reports database includes information about shortages of reportable medicines in Australia, including those arising from the discontinuation of products.
You can use this page to search for all medicines in shortage and find information about management actions, including supply of overseas alternative medicines.
Information in this database is based on details reported to us by sponsors. Any additional management actions taken by us will be clearly stated.
How to search
The database defaults to all current medicine shortages. You can also view anticipated and resolved shortages and discontinuations.
To search the database for all shortages and discontinuations for a particular medicine, type the active ingredient or trade (brand) name into the search field. You can then click on the active ingredient name or trade name for more information about the shortage of interest.
You can also download an extract of all shortages and discontinuations.
To view all medicines shortages and discontinuations with a critical shortage impact rating, click on the CRITICAL medicine shortages link below.
Further information
Information about medicine shortages is available at the Medicine Shortages hub
Subscribe to Medicine Shortages updates
You can subscribe to Medicine Shortages Email Alerts or the Medicine Shortages RSS feed for frequently updated information.
This service does not support Internet Explorer 7 and below.
Search Results
Browse CRITICAL shortages and discontinuations
Click here to display ALL medicine shortages and discontinuations
AUST R: 14332
Expected supply: 31 Dec 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. Please contact the approval holder for details on supply: Global Medical Solutions Australia Pty Limited T/A Radpharm Scientific - Ph: 02 9503 8100
Updated: 29-11-2022
phenoxybenzamine hydrochloride
AUST R: 12980
Expected supply: 30 Jun 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website:Ā https://www.tga.gov.au/ws-s19a-indexĀ and search for the active ingredient.
Updated: 21-10-2022
dantrolene sodium hemiheptahydrate
DANTRIUM dantrolene sodium hemiheptahydrate 25mg capsule bottle
AUST R: 42975
Expected supply: 31 Dec 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website:Ā https://www.tga.gov.au/ws-s19a-indexĀ and search for the active ingredient.
Updated: 17-06-2022
dantrolene sodium hemiheptahydrate
DANTRIUM dantrolene sodium hemiheptahydrate 50mg capsule bottle
AUST R: 42976
Expected supply: 31 Dec 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website:Ā https://www.tga.gov.au/ws-s19a-indexĀ and search for the active ingredient.
Updated: 26-07-2022
Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain)
ONCOTICE BCG 5 hundred million CFU powder for injection vial
AUST R: 59912
Expected supply: 31 Dec 2024
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 07-03-2022
CIPLA BLEOMYCIN 15K bleomycin sulfate 15000 IU powder for injection vial
AUST R: 220440
Expected supply: 30 Jun 2021
Availability: Unavailable
Management action: Alternative brands are available.
Updated: 16-06-2022
ETHYOL Amifostine (as trihydrate) 500mg powder for injection vial
AUST R: 63789
Expected supply: 31 Jul 2023
Availability: Unavailable
Management action: Alternative unapproved products available under the Special Access Scheme.
Updated: 27-07-2022
DBL SULFAMETHOXAZOLE 400 mg and TRIMETHOPRIM 80 mg/5 mL concentrated injection ampoule
AUST R: 16293
Expected supply: 10 Mar 2023
Availability: Unavailable
Updated: 18-01-2023
AUST R: 101670
Expected supply: 31 Dec 2022
Availability: Unavailable
Management action: Alternative unapproved products available under the Special Access Scheme (SAS). For further information about the SAS scheme please see https://www.tga.gov.au/form/special-access-scheme
Updated: 16-12-2021
tetracosactide (tetracosactrin)
SYNACTHEN DEPOT tetracosactide (tetracosactrin) zinc complex 1mg/1m L injection ampoule
AUST R: 11060
Expected supply: 30 Nov 2023
Availability: Unavailable
Management action: Alternative unapproved products available under the Special Access Scheme (SAS). For further information about the SAS scheme please see https://www.tga.gov.au/form/special-access-scheme
Updated: 15-11-2022
procaine benzylpenicillin (procaine penicillin)
CILICAINE SYRINGE 1.5 procaine benzylpenicillin (procaine penicillin) 1.5g injection syringe
AUST R: 288818
Expected supply: 31 Dec 2022
Availability: Unavailable
Updated: 14-12-2022
HYDRALAZINE LINK hydralazine hydrochloride 20 mg/1 mL solution for injection vial
AUST R: 272644
Expected supply: 30 Jun 2024
Availability: Unavailable
Management action: Alternative generic products may be available
Updated: 24-01-2023
AUST R: 235933
Expected supply: 31 Dec 2022
Availability: Unavailable
Management action: Alternative generic products are available.
Updated: 14-06-2022
CARBOSORB XS activated charcoal 50 g/250 mL and sorbitol 70.75 g/250 mL suspension bottle
AUST R: 307429
Expected supply: 31 Mar 2023
Availability: Unavailable
Updated: 01-11-2022
dexamethasone sodium phosphate
DBL DEXAMETHASONE SODIUM PHOSPHATE INJECTION 4mg/1mL (as sodium) injection ampoule
AUST R: 16374
Expected supply: Unknown
Availability: Unavailable
Management action: An alternate presentation of the same strength is available.
Updated: 15-08-2022
adrenaline (epinephrine) acid tartrate
lidocaine (lignocaine) hydrochloride
XYLOCAINE 0.5% WITH ADRENALINE 1:200,000 20mL injection vial
AUST R: 12008
Expected supply: 28 Feb 2023
Availability: Unavailable
Management action: An unregistered product in another strength has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 17-08-2022
AUST R: 48231
Expected supply: 03 Feb 2023
Availability: Unavailable
Management action: Alternative generic products are available
Updated: 11-01-2023
TOFRANIL 25 imipramine hydrochloride 25mg tablet blister pack
AUST R: 60673
Expected supply: 31 Dec 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 16-01-2023
AUST R: 81930
Expected supply: 30 Apr 2023
Availability: Unavailable
Updated: 03-05-2022
AUST R: 81931
Expected supply: 30 Apr 2023
Availability: Unavailable
Updated: 03-05-2022
FUNNEL WEB SPIDER ANTIVENOM (RABBIT) 125U powder for injection vial
AUST R: 31847
Expected supply: 30 Apr 2023
Availability: Available
Management action: Sponsor is closely controlling the supply.
Updated: 03-02-2023
dexamethasone sodium phosphate
AUST R: 163200
Expected supply: 31 Oct 2023
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, Alphapharm Pty Ltd can be contacted on 1800 274 276 for details on supply
Updated: 02-02-2023
METALYSE tenecteplase (rch) 50mg powder for injection vial plus prefilled syringe
AUST R: 75013
Expected supply: 31 Mar 2023
Availability: Limited Availability
Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-tenecteplase-metalyse. The TGA has approved a shelf-life extension of certain batches of Metalyse by 12 months, information on batch numbers and extended expiry dates is available in the web statement.
Unregistered alternative products have been approved for supply under Section 19A. For information on supply, contact the approval holder, Pro Pharmaceuticals Group Pty Ltd on 1300 077 674.
Updated: 13-07-2022
AUST R: 13537
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, ORSPEC Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.
Updated: 03-01-2023
AUST R: 94175
Expected supply: 28 Feb 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 21-12-2022
adrenaline (epinephrine) acid tartrate
ADRENALINE-LINK 1:10,000 1mg/10mL adrenaline (epinephrine) acid tartrate injection BP ampoule
AUST R: 119194
Expected supply: Unknown
Availability: Unavailable
Updated: 27-01-2023
AUST R: 49945
Expected supply: 15 Dec 2022
Availability: Available
Updated: 15-12-2022
AUST R: 49422
Expected supply: 30 Apr 2023
Availability: Unavailable
Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-iodinated-contrast-media-contrast-diagnostic-agents.
Ā
An unregistered alternative product has been approved for supply under Section 19A. The approval holder, Guerbet Australia Pty Ltd can be contacted on 02 8075 3007 for details on supply
Updated: 22-12-2022
AUST R: 47996
Expected supply: 30 Apr 2023
Availability: Unavailable
Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-iodinated-contrast-media-contrast-diagnostic-agents.
Ā
An unregistered alternative product has been approved for supply under Section 19A. The approval holder, Guerbet Australia Pty Ltd can be contacted on 02 8075 3007 for details on supply
Updated: 22-12-2022
AUST R: 47997
Expected supply: 30 Apr 2023
Availability: Unavailable
Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-iodinated-contrast-media-contrast-diagnostic-agents.
Ā
An unregistered alternative product has been approved for supply under Section 19A. The approval holder, Guerbet Australia Pty Ltd can be contacted on 02 8075 3007 for details on supply
Updated: 22-12-2022
AUST R: 47998
Expected supply: 30 Apr 2023
Availability: Unavailable
Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-iodinated-contrast-media-contrast-diagnostic-agents.
Ā
An unregistered alternative product has been approved for supply under Section 19A. The approval holder, Guerbet Australia Pty Ltd can be contacted on 02 8075 3007 for details on supply
Updated: 22-12-2022
naloxone hydrochloride dihydrate
NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial
AUST R: 309381
Expected supply: 29 Dec 2022
Availability: Available
Updated: 03-01-2023
DBL VANCOMYCIN vancomycin (as hydrochloride) 500mg powder for injection vial
AUST R: 62603
Expected supply: Unknown
Availability: Unavailable
Management action: An alternative brand is available
Updated: 21-11-2022
DBL LEUCOVORIN CALCIUM folinic acid 15 mg/2mL (as calcium folinate) injection ampoule
AUST R: 16351
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternate strengths available
Updated: 08-06-2022
METALYSE tenecteplase (rch) 40mg powder for injection vial plus prefilled syringe
AUST R: 75012
Expected supply: 31 Mar 2023
Availability: Limited Availability
Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-tenecteplase-metalyse. The TGA has approved a shelf-life extension of certain batches of Metalyse by 12 months, information on batch numbers and extended expiry dates is available in the web statement.
Updated: 13-07-2022
VORICONAZOLE WOCKHARDT voriconazole 200 mg powder for injection vial
AUST R: 267013
Expected supply: 31 Mar 2023
Availability: Unavailable
Management action: Alternative generic products are available.
Updated: 11-01-2023
MESTINON TIMESPAN pyridostigmine bromide 180mg tablet bottle
AUST R: 13749
Expected supply: 06 Feb 2023
Availability: Unavailable
Management action: Sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. Please contact the approval holder for details on supply: Medsurge Healthcare Pty Ltd - Ph: 1300 788 261
Updated: 01-02-2023
Influenza virus haemagglutinin
AUST R: 242512
Expected supply: 01 Apr 2023
Availability: Limited Availability
Management action: Seasonal depletion of stock.
An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 22-07-2022
DUKORAL oral inactivated cholera vaccine liquid vial and buffer powder sachet
AUST R: 94483
Expected supply: 22 Dec 2022
Availability: Available
Updated: 23-12-2022
ACTILYSE alteplase (rch) 50 mg powder for injection vial with diluent vial
AUST R: 17905
Expected supply: 31 Dec 2023
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply. A TGA web statement is available atĀ https://www.tga.gov.au/alert/shortage-tenecteplase-metalyse
Updated: 27-01-2023
ACTILYSE alteplase (rch) 10mg powder for injection vial with water for injections 10mL vial
AUST R: 64240
Expected supply: 31 Dec 2023
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply. A TGA web statement is available at https://www.tga.gov.au/alert/shortage-tenecteplase-metalyse.
Updated: 27-01-2023
PRIORIX-TETRA vaccine 0.5mL powder for injection vial with diluent syringe
AUST R: 107286
Expected supply: 15 Nov 2022
Availability: Available
Updated: 17-11-2022
Updated: 15-12-2022
AUST R: 223583
Expected supply: 01 Mar 2023
Availability: Limited Availability
Updated: 07-09-2022
DBL CIPROFLOXACIN 200 mg/100 mL injection for intravenous infusion bag
AUST R: 123041
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Updated: 24-01-2023
DBL CIPROFLOXACIN 400 mg/200 mL injection for intravenous infusion bag
AUST R: 123042
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Updated: 24-01-2023
AUST R: 48230
Expected supply: 29 Nov 2022
Availability: Available
Updated: 29-11-2022
Equine antithymocyte immunoglobulin
ATGAM equine antithymocyte immunoglobulin 250mg/5mL injection ampoule
AUST R: 12282
Expected supply: 24 Feb 2023
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply. Alternative unapproved products available under the Special Access Scheme. For further information please seeĀ http://www.tga.gov.au/form/special-access-scheme
Updated: 09-12-2022
MYLOTARG gemtuzumab ozogamicin 5 mg powder for injection vial
AUST R: 316671
Expected supply: 26 Dec 2022
Availability: Available
Management action: The sponsor is closely controlling the supply and working to expedite the next shipment.
Updated: 03-11-2022
HEPARIN SODIUM 5000IU/5mL (porcine mucous) injection ampoule
AUST R: 49232
Expected supply: 31 Mar 2023
Availability: Limited Availability
Management action: Sponsor is working to expedite the next shipment
Updated: 11-01-2023
TECHNESCAN HDP kit for preparation of Technetium [99mTc] oxidronate powder for injection vial
AUST R: 75500
Expected supply: 30 Jun 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 14-12-2022
AUST R: 13748
Expected supply: 31 Dec 2022
Availability: Available
Updated: 04-01-2023
ONCASPAR pegaspargase 3750 units/5mL powder for solution injection/infusion vial
AUST R: 303807
Expected supply: 01 Mar 2023
Availability: Available
Updated: 30-11-2022
AUST R: 78702
Expected supply: 03 Feb 2023
Availability: Available
Updated: 03-02-2023
AUST R: 14861
Expected supply: 05 Dec 2022
Availability: Available
Updated: 06-12-2022
dantrolene sodium hemiheptahydrate
DANTRIUM dantrolene sodium hemiheptahydrate 20mg powder for injection vial
AUST R: 14435
Expected supply: 24 Feb 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder can be contacted for details on supply: Link Medical Products - 1800 181 060 or email customerservice@linkhealthcare.com.au
Updated: 01-02-2023
Updated: 09-01-2023
AUST R: 115008
Expected supply: 20 Jan 2023
Availability: Available
Updated: 20-01-2023
CALCIUM GLUCONATE GEL calcium gluconate monohydrate 25mg/g gel tube
AUST R: 11320
Expected supply: 18 Nov 2022
Availability: Available
Updated: 30-11-2022
Pfizer (Australia) METRONIDAZOLE 5mg/mL (0.5%) injection vial
AUST R: 12728
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic products are available.
Updated: 24-11-2022
AUST R: 61885
Expected supply: 03 Feb 2023
Availability: Available
Updated: 03-02-2023
DBL VANCOMYCIN vancomycin (as hydrochloride) 1000 mg powder for injection vial
AUST R: 62595
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: An alternative brand is available
Updated: 14-12-2022
AUST R: 79745
Expected supply: 12 Jan 2023
Availability: Available
Updated: 16-01-2023
IBIMICYN ampicillin 500mg (as sodium) powder for injection vial
AUST R: 92839
Expected supply: 15 Mar 2023
Availability: Limited Availability
Management action: Another strength is available.
Updated: 13-01-2023
phenoxymethylpenicillin potassium
ASPECILLIN VK phenoxymethylpenicillin 250mg (as potassium) tablet bottle
AUST R: 200136
Expected supply: 28 Feb 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder can be contacted for details on supply: Medsurge Pty Ltd - 1300 788 261 or email sales@medsurge.com.au
Updated: 11-01-2023
phenoxymethylpenicillin potassium
AUST R: 159753
Expected supply: 28 Feb 2023
Availability: Unavailable
Management action: Sponsor is working to expedite the next shipment.
Updated: 10-01-2023
phenoxymethylpenicillin potassium
AUST R: 159754
Expected supply: 28 Feb 2023
Availability: Unavailable
Management action: Sponsor is working to expedite the next shipment.
Updated: 10-01-2023
AUST R: 67398
Expected supply: 22 Dec 2022
Availability: Available
Updated: 23-12-2022
AUST R: 115049
Expected supply: 21 Dec 2022
Availability: Available
Updated: 21-12-2022
AUST R: 42279
Expected supply: 31 Jul 2023
Availability: Emergency Supply Only
Updated: 27-01-2023
HEPARIN SODIUM 25000IU/5mL (porcine mucous) injection ampoule
AUST R: 49236
Expected supply: 01 Feb 2023
Availability: Available
Updated: 01-02-2023
ASPEN ADRENALINE INJECTION adrenaline (epinephrine) 1 mg/10 mL solution for injection ampoule
AUST R: 162463
Expected supply: 06 Feb 2023
Availability: Unavailable
Management action: Sponsor is working to expedite the next shipment.
Updated: 24-01-2023
phenoxymethylpenicillin benzathine
CILICAINE V phenoxymethylpenicillin (as benzathine) 150mg/5mL oral liquid, suspension bottle
AUST R: 151598
Expected supply: 30 Apr 2023
Availability: Emergency Supply Only
Management action: Sponsor is working to expedite the next shipment.
Updated: 16-12-2022
VOXZOGO vosoritide 0.4 mg powder for injection vial and diluent pre-filled syringe
AUST R: 376616
Expected supply: 31 Jul 2023
Availability: Available
Management action: Delayed product launch
Updated: 17-01-2023
VOXZOGO vosoritide 0.56 mg powder for injection vial and diluent pre-filled syringe
AUST R: 376617
Expected supply: 31 Jul 2023
Availability: Available
Management action: Delayed product launch
Updated: 17-01-2023
VOXZOGO vosoritide 1.2 mg powder for injection vial and diluent pre-filled syringe
AUST R: 376618
Expected supply: 31 Jul 2023
Availability: Available
Management action: Delayed product launch
Updated: 17-01-2023
CARBOSORB X activated charcoal 50 g/250 mL suspension bottle
AUST R: 106470
Expected supply: 10 Feb 2023
Availability: Unavailable
Management action: Sponsor is working to expedite the next shipment.
Updated: 20-12-2022
AUST R: 73173
Expected supply: 30 Jun 2023
Availability: Limited Availability
Management action: Another strength is available.
Updated: 03-02-2023
VENTOLIN OBSTETRIC salbutamol 5mg/5mL (as sulfate) injection ampoule
AUST R: 12528
Expected supply: 01 Aug 2023
Availability: Available
Management action: The sponsor is closely controlling the supply.
Updated: 20-01-2023
adrenaline (epinephrine) acid tartrate
ADRENALINE-LINK 1:1,000 1mg/1mL adrenaline (epinephrine) acid tartrate injection BP ampoule
AUST R: 12048
Expected supply: 30 Apr 2023
Availability: Available
Management action: 5 x 1mL pack size is available.
Updated: 24-01-2023
AUST R: 39954
Expected supply: 10 Feb 2023
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply and working to expedite the next shipment.
Updated: 19-01-2023
HEPARINISED SALINE 50IU/5mL (porcine mucous) injection ampoule
AUST R: 66684
Expected supply: 05 May 2023
Availability: Available
Management action: The sponsor is closely controlling the supply and working to expedite next shipment.
Updated: 25-01-2023
AUST R: 12513
Expected supply: 01 Mar 2023
Availability: Emergency Supply Only
Updated: 27-01-2023
AUST R: 46451
Expected supply: 11 Aug 2023
Availability: Available
Updated: 27-01-2023
betamethasone sodium phosphate
CELESTONE CHRONODOSE betamethasone 5.7mg/1mL (as acetate and sodium phosphate) injection ampoule
AUST R: 18777
Expected supply: 31 Aug 2023
Availability: Limited Availability
Updated: 03-02-2023
{{headingLabels[selectedTab]}}
Sort by: Updated date | Active ingredient | Trade name | Therapeutic class
URL: http://apps.tga.gov.au/prod/MSI/search/